These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11186189)

  • 1. Drug resistance. An updated, user-friendly guide to genotype interpretation.
    MacArthur RD
    AIDS Read; 2000 Nov; 10(11):652-7. PubMed ID: 11186189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province].
    Yang K; Li JY; Bao ZY; Li HP; Li L; Zhuang DM; Wang Z; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):351-5. PubMed ID: 16053762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
    Si XF; Huang HL; Wei M; Guan Q; Song YH; Ma PF; Quan Y; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):308-11. PubMed ID: 15650776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
    Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities.
    Sullivan PS; Buskin SE; Turner JH; Cheingsong R; Saekhou A; Kalish ML; Jones JL; Respess R; Kovacs A; Heneine W
    Int J STD AIDS; 2002 Aug; 13(8):554-8. PubMed ID: 12194739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance testing debate: does it make the grade?
    Simmons P
    Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.
    Vergne L; Diagbouga S; Kouanfack C; Aghokeng A; Butel C; Laurent C; Noumssi N; Tardy M; Sawadogo A; Drabo J; Hien H; Zekeng L; Delaporte E; Peeters M
    Antivir Ther; 2006; 11(5):575-9. PubMed ID: 16964825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV resistance testing: an update.
    Aslanzadeh J
    Ann Clin Lab Sci; 2002; 32(4):406-13. PubMed ID: 12458895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-1 polymerase gene mutations in pre-treated patients in Thailand.
    Chantratita W; Jenwitheesuk E; Watitpun C; Pongthanapisith V; Vibhagool A; Leechawengwong M; Sookpranee M; Apairatana A
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):80-4. PubMed ID: 12118466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV resistance testing proves its value.
    Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients.
    Vergne L; Snoeck J; Aghokeng A; Maes B; Valea D; Delaporte E; Vandamme AM; Peeters M; Van Laethem K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):53-62. PubMed ID: 16420597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.
    Svedhem V; Lindkvist A; Lidman K; Sönnerborg A
    J Med Virol; 2002 Dec; 68(4):473-8. PubMed ID: 12376953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance to non-nucleoside reverse transcriptase inhibitors].
    Casado JL; López JC; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):30-3. PubMed ID: 11428057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.